Actuate Therapeutics (ACTU) Q4 2024 Earnings

13NovConfirmed
Q4 2024
-0.55
-0.22
0.12
0.45

Details

Expected EPS
-0.55
Actual EPS
N/A
Surprise EPS
0.55
Surprise Percent
+100%

Description

Actuate Therapeutics (ACTU) will report earnings of for Q4 2024 on November 13, 2024.

0 Comments

Share your thoughts